Search

Displaying results 7641 - 7650 of 10000 in total
  1. Drug

    Echinacea

    go.drugbank.com/drugs/DB14240
    Approved

    Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers
  2. Drug

    Saw palmetto

    go.drugbank.com/drugs/DB14360
    Approved

    Saw palmetto is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Categories: Complex Mixtures, Cytochrome P-450 CYP2C8 InhibitorsSynonyms: Saw Palmetto Fruit (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols)), Sabalis Serrulatae Fructus (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols))
  3. Drug

    Calcium phosphate dihydrate

    go.drugbank.com/drugs/DB14481
    Approved

    Mixtures: NAVI Black and C-Clinic
  4. Drug

    Zinc acetate

    go.drugbank.com/drugs/DB14487
    ApprovedInvestigational

    Mixtures: Diphenhydramine D, CALPRAX CLEAR®Products: Senior B, Neat 3B Baby B
  5. Drug

    Lithium citrate

    go.drugbank.com/drugs/DB14507
    ApprovedInvestigational

  6. Drug

    Hydrocortisone phosphate

    go.drugbank.com/drugs/DB14542
    ApprovedInvestigationalVet approved

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 Inducers
  7. Drug

    Prednisolone hemisuccinate

    go.drugbank.com/drugs/DB14633
    Investigational

    Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 InducersProducts: Solu-Dacortin 1 g - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung oder Infusionslösung
  8. Drug

    Willow bark

    go.drugbank.com/drugs/DB14691
    Approved

    Mixtures: Miller's Formula No. 1Categories: Complex Mixtures
  9. Drug

    Cycloguanil

    go.drugbank.com/drugs/DB14763
    Approved

    Cycloguanil is the active metabolite of proguanil.

    Categories: Heterocyclic Compounds, 1-Ring
  10. Drug

    Etrasimod

    go.drugbank.com/drugs/DB14766
    ApprovedInvestigational

    Etrasimod is a synthetic next-generation selective Sphingosine 1-phosphate (S1P) receptor modulator that targets the S1P<sub>1,4,5</sub> with no detectable activity on S1P<sub>2</sub> and S1P<sub>3</sub … [L48501] The European Commission also approved the marketing of etrasimod on February 19, 2024.[L50998]

    Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 2-Ring